Mark Levin - Director, 10%+ Owner at Fulcrum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
FULC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Levin since 10/27/2024

Holdings reported by Mark Levin for Fulcrum Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.96M $13.1M $3.31 Nov 10, 2021 Indirect
Common Stock 75.8K $251K $3.31 Nov 10, 2021 Direct
Stock Option (right to buy) 15K Jun 9, 2021 Direct Common Stock

Transactions reported by Mark Levin for Fulcrum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.